The longer term outcome of children born to mothers with epilepsy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 11, 2004, Pages 1575-1583

  Adab, N ^a   Kini, U ^b   Vinten, J ^a   Ayres, J ^b   Baker, G ^a   Clayton Smith, J ^b   Coyle, H ^c   Fryer, A ^d   Gorry, J ^a   Gregg, J ^d   Mawer, G ^c   Nicolaides, P ^d   Pickering, L ^a   Tunnicliffe, L ^a   Chadwick, D W ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ARTICLE; CHILD; COGNITIVE DEFECT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EXPOSURE; EPILEPSY; GRAND MAL EPILEPSY; HUMAN; INFANT; INTELLIGENCE QUOTIENT; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTCOMES RESEARCH; PATIENT COUNSELING; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PSYCHOMETRY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SIDE EFFECT; VERBAL BEHAVIOR;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; DRUG THERAPY, COMBINATION; ENGLAND; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTELLIGENCE; INTELLIGENCE TESTS; MALE; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; VALPROIC ACID;

EID: 7244257375     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.029132     Document Type: Article

References (58)

1. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352(9145):1970- 3.
2. Fairgrieve SD, Jackson M, Jonas P, et al. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ 2000;321(7262):674-5.
3. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344(15):1132-8.
4. Battino D, Binelli S, Caccamo ML, et al. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992;85(3):204-7.
5. Samren EB, van Duijn CM, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38(9):981-90.
6. Keneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33(2-3);145-58.
7. Hill RM, Verniaud WM, Horning MG, et al. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child 1974;127(5):645-53.
8. Hanson JW, Myrianthopoulos NC, Harvey MA, et al. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 1976;89(4):662-8.
9. Hill RM, Verniaud WM, Rettig GM, et al. Relation between antiepileptic drug exposure of the infant and developmental potential. In: Janz D, Dam M, Richens A, et al, eds. Epilepsy, pregnancy and the child. New York: Raven Press, 1982:409-17.
10. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;2(7782):839-43.
11. DiLiberti JH, Farndon PA, Dennis NR, et al. The fetal valproate syndrome. Am J Med Genet 1984;19(3):473-81.
12. Jones KL, Lacro RV, Johnson KA, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320(25):1661-6.
13. Clayton-Smith J, Donnai D. Fetal valproate syndrome. J Med Genet 1995;32(9):724-7.
14. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996;75(6):517-20.
15. Mawer G, Clayton-Smith J, Coyle H, et al. Outcome of pregnancy in women attending outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 2002;11:512-8.
16. Gaily E, Granstrom ML. Minor anomalies in children of mothers with epilepsy. Neurology 1992;42(4 suppl 5):128-31.
17. Nulman I, Scolnik D, Chitayat D, et al. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet 1997;68(1):18-24.
18. Majewski F, Steger M, Richter B, et al. The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 1981;2(1):37-45.
19. Beck-Mannagetta G, Janz D. Data on psychomotor and mental development in children of epileptic mothers: a retrospective study. In: Janz D, Dam M, Richens A, et al, eds. Epilepsy, pregnancy and the child. New York: Raven Press, 1982:443-5.
20. Dean JC, Hailey H, Moore SJ, et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002;39(4):251-9.
21. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy [see comments]. JAMA 1994;271(10):767-70 [published erratum appears in JAMA 1994;271(22):1745].
22. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy [see comments]. JAMA 1994;271(10):767-70 [published erratum appears in JAMA 1994;271(22):1745].
23. Fujioka K, Kaneko S, Hirano T, et al. A study of the psychomotor development of the offspring of epileptic mothers. In: Sato T, Shinagawa S, eds. Antiepileptic drugs and pregnancy. Amsterdam: Excerpta Medica, 1984:196-206.
24. Leavitt AM, Yerby MS, Robinson N, et al. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology 1992;42(4 suppl 5):141-3.
25. Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the development of birth defects, Lancet 1976;1(7954):272-5.
26. Gaily E, Kantola-Sorsa E, Granstrom ML. Intelligence of children of epileptic mothers. J Pediatr 1988;113(4):677-84.
27. van der Pol MC, Hadders-Algra M, Huisjes HJ, et al. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol 1991;164(1 Pt 1):121-8.
28. Wide K, Henning E, Tomson T, et al. Psychomotor development in pre-school children exposed to antiepileptic drugs. Acta Paediatr 2002;91(4):409-14.
29. Vanoverloop D, Schnell RR, Harvey EA, et al. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 1992;14(5):329-35.
30. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996;75(6):517-20.
31. Ohtsuka Y, Silver K, Lopes-Cendes I, et al. Effect of antiepileptic drugs on psychomotor development of offspring of epileptic mothers [abstract]. Epilepsia 1999;40(suppl 2):296.
32. James F, Lynch SA, Fairgrieve SD, et al. A prospective population based study of developmental delay and craniofacial dysmorphism in children born to women with epilepsy [abstract]. J Med Genet 2000;37(S1):S67.
33. Gaily E, Kantola-Sorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990;32(5):403-14.
34. Steinhausen HC, Losche G, Koch S, et al. The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr 1994;83(9):955-60.
35. Adab N, Jacoby A, Smith D, et al. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatr 2001;70(1):15-21.
36. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
37. Moore SJ, Turnpenny P, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000;37(7):489-97.
38. EUROCAT Guide 1.2, University of Ulster, 2002. http:// www.eurocat.ulster.ac.uk/ (accessed 1 August 2004).
39. Wechsler D, Golombok S, Rust J. Wechsler Intelligence Scale for Children, 3rd ed. UK Manual. Sidcup, UK: The Psychological Corporation, 1992.
40. Bellman M, Lingam S, Aukett A. Schedule of Growing Skills (SGS II) manual. UK: NFER-NELSON, 1996.
41. Nelson HE. National Adult Reading Test (NART): test manual, 2nd ed. UK: NFER-NELSON, 1982.
42. The National Statistics Socio-economic Classification (NS-SEC), 2001. http:// www.statistics.gov.uk/methods_quality/ns_sec/default.asp (accessed 1 August 2004).
43. Department of Health, Welsh Office, Scottish Home and Health Department, and Department of Health and Social Services Northern Ireland. Report on confidential enquiry into maternal deaths in the UK, 1985-1987. London: HMSO, 1989.
44. Department of Health, Welsh Office, Scottish Home and Health Department, and Department of Health and Social Services Northern Ireland. Report on confidential enquiry into maternal deaths in the UK, 1988-1990. London: HMSO, 1992.
45. Department of Health: Welsh Office, Scottish Home and Health Department, and Department of Health and Social Services Northern Ireland. Report on confidential enquiry into maternal deaths in the UK, 1991-1993. London: HMSO, 1995.
46. Department of Health, Welsh Office, Scottish Home and Health Department, and Department of Health and Social Services Northern Ireland. Why mothers die - report on confidential enquiry into maternal deaths in the UK, 1994-1996. London: The Stationery Office, 1998.
47. The Scottish Executive Health Department, The National Institute for Clinical Excellence, The Department of Health, Social Services and Public Safety: Northern Ireland. Why mothers die - report on confidential enquiry into maternal deaths in the UK, 1997-1999. London: RCOG Press, 2001.
48. Hauser WA, Hesdorffer DC. Epilepsy: frequency, causes and consequences. New York: Demos Publications, 1990.
49. Lhafoo SD, Johnson AL, Goodridge DM, et al. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49(3):336-44.
50. Shorvon S. Antiepileptic drugs in pregnancy: the neurologist's perspective. J Med Genet 2002;39:248-250.
51. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004;62(1):28-32.
52. Dean JCS, Moore SJ, Osborne A, et al. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet 1999;56(3):216-20.
53. Marson AG, Williamson PR, Clough H, et al. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002;43(5):505-13.
54. The Scottish Intercollegiate Guidelines Network (SIGN). Guideline 70. http://www.sign.ac.uk/guidelines/published/index.html (accessed 9 August 2004).
55. Nicolson A, Appleton R, Chadwick D, Smith D. Relationship between treatment with valproate, lamotrigine and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatr 2004;75(1):75-9.
56. Craig J, Russell A, Parsons L, et al. The UK Epilepsy and Pregnancy Register: update of results 1996-2002 [abstract]. Epilepsia 2002;43(S8):56.
57. Tennis P, Eldridge RR, and the International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 2002;43(10):1161-7.
58. Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984;34:285-94.